When most investors think space stocks, SpaceX comes to mind—reusable boosters, Starlink, Mars ambitions. But a new crop of publicly traded companies is attempting to prove that the real money in orbit lies not in launching rockets, but in monetizing what happens after they get there. Rocket Lab (RKLB) and AST SpaceMobile represent two of the most-watched names in this thesis, yet their current valuations have left some institutional analysts questioning whether the market has gotten ahead of reality.

Market Context

Space-related equities have attracted renewed retail interest as more companies transition from development stages to operational revenue generation. The broader aerospace and defense sector has seen increased M&A activity, while satellite-based communications networks promise recurring monthly revenue streams—a feature that typically commands premium valuations in the technology complex. Against this backdrop, Rocket Lab has emerged as the closest publicly traded analog to SpaceX, though its valuation metrics suggest investors are pricing in a future that remains firmly under construction.

Analysis

Rocket Lab's bull case rests on its dual-rocket operational portfolio—Electron for small-cargo low-Earth orbit deliveries and HASTE for hypersonic test flights—combined with the anticipated Neutron reusable rocket meant to compete directly with SpaceX's Falcon 9. However, the company has experienced delays with Neutron development, eroding some investor confidence in its timeline. The stock currently trades at approximately 82 times sales, a multiple that implies significant future growth materialization. This valuation stands in contrast to the article's observation that 'some space companies are selling you the dream—the rocket that isn't finished yet; the network that hasn't gone live; the future that hasn't quite arrived.' The question for institutional allocators is whether Rocket Lab falls into the category of companies already cashing checks or those still awaiting their opening scene.

The company has carved a niche serving commercial and government customers seeking dedicated small-payload launches without competing for SpaceX's congested manifest. Electron has successfully completed multiple missions, providing a track record that distinguishes Rocket Lab from pre-revenue competitors. Yet the valuation premium reflects market expectations for Neutron to unlock larger contracts and improve unit economics—a bet that hinges on execution within an already-extended timeline.

Key Numbers

- Rocket Lab (RKLB) valuation: 82X sales multiple

- Operational rockets: Electron and HASTE currently active

- Neutron rocket status: under development with recent delays

- Company founding year: 2006

- Primary market focus: low-Earth orbit cargo delivery, hypersonic testing

What to Watch

Investors should monitor Rocket Lab's next earnings release for updated Neutron development timelines and any announcements regarding contract awards or launch manifest additions. Key technical levels to watch include the stock's 50-day moving average as a near-term support indicator and previous resistance around $20-$22 per share. Any news on Neutron test milestones—such as engine firings or structural testing updates—could serve as catalysts for re-rating the shares. Additionally, broader space sector M&A activity could impact sentiment toward RKLB, particularly if larger aerospace players announce consolidation moves targeting small-launch capabilities.